Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 28 entries
View as:

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05323253 Org: User:
Start: 09/21/22 End: 12/31/25 Due: 12/31/26

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04377360 Org: User:
Start: 01/06/20 End: 03/28/22 Due: 03/28/23

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06026943 Org: User:
Start: 01/31/25 End: 01/31/28 Due: 01/31/29

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03015883 Org: User:
Start: 02/22/17 End: 06/25/19 Due: 06/25/20

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Phase: N/A Priority: Normal
NCT ID: NCT04540588 Org: User:
Start: 12/22/20 End: 01/01/26 Due: 01/01/27

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

Phase: N/A Priority: Normal
NCT ID: NCT06202339 Org: User:
Start: 04/30/24 End: 12/31/26 Due: 12/31/27

A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06202248 Org: User:
Start: 03/12/24 End: 06/30/27 Due: 06/30/28

Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)

Phase: N/A Priority: Normal
NCT ID: NCT05829291 Org: User:
Start: 10/01/23 End: 02/28/26 Due: 02/28/27

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03970967 Org: User:
Start: 08/28/19 End: 11/30/23 Due: 11/30/24

Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05632913 Org: User:
Start: 07/01/23 End: 02/28/27 Due: 02/28/28

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06755359 Org: User:
Start: 04/30/25 End: 06/30/27 Due: 06/30/28

Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04543903 Org: User:
Start: 05/16/22 End: 05/01/27 Due: 05/01/28

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05657743 Org: User:
Start: 08/16/23 End: 11/30/25 Due: 11/30/26

Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients

Phase: N/A Priority: Normal
NCT ID: NCT06615635 Org: User:
Start: 12/31/24 End: 12/31/26 Due: 12/31/27

A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT

Phase: N/A Priority: Normal
NCT ID: NCT05125354 Org: User:
Start: 01/06/22 End: 03/06/22 Due: 03/06/23

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04002479 Org: User:
Start: 10/20/20 End: 10/31/26 Due: 10/31/27

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

Phase: N/A Priority: Normal
NCT ID: NCT03886181 Org: User:
Start: 07/08/21 End: 10/31/25 Due: 10/31/26

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Phase: N/A Priority: Normal
NCT ID: NCT03889899 Org: User:
Start: 10/21/20 End: 09/30/26 Due: 09/30/27

A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC

Phase: N/A Priority: Normal
NCT ID: NCT05047094 Org: User:
Start: 11/02/21 End: 06/30/27 Due: 06/30/28

A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05781555 Org: User:
Start: 03/22/23 End: 04/30/25 Due: 04/30/26

Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC

Phase: N/A Priority: Normal
NCT ID: NCT05065346 Org: User:
Start: 03/31/25 End: 06/30/26 Due: 06/30/27

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04068155 Org: User:
Start: 04/01/22 End: 01/31/25 Due: 01/31/26

A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Phase: N/A Priority: Normal
NCT ID: NCT06202118 Org: User:
Start: 02/19/24 End: 06/30/26 Due: 06/30/27

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Phase: N/A Priority: Normal
NCT ID: NCT03353077 Org: User:
Start: 11/21/17 End: 07/14/19 Due: 07/14/20

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Phase: N/A Priority: Normal
NCT ID: NCT03737734 Org: User:
Start: 12/31/18 End: 12/31/25 Due: 12/31/26